Biomarkers and Mortality After Transient Ischemic Attack and Minor Ischemic Stroke: Population-Based Study
暂无分享,去创建一个
P. Rothwell | Z. Mehta | H. Segal | S. Greisenegger | A. Burgess | D. Poole
[1] E. Mohammadi,et al. Barriers and facilitators related to the implementation of a physiological track and trigger system: A systematic review of the qualitative evidence , 2017, International journal for quality in health care : journal of the International Society for Quality in Health Care.
[2] P. Rothwell,et al. Population-Based Study of Blood Biomarkers in Prediction of Subacute Recurrent Stroke , 2014, Stroke.
[3] W. Freeman,et al. B-type natriuretic peptides and mortality after stroke: A systematic review and meta-analysis , 2014, Neurology.
[4] H. Bøtker,et al. Eighteen-year trends in stroke mortality and the prognostic influence of comorbidity , 2014, Neurology.
[5] J. Murabito,et al. Multiple Inflammatory Biomarkers in Relation to Cardiovascular Events and Mortality in the Community , 2013, Arteriosclerosis, thrombosis, and vascular biology.
[6] S. Moebus,et al. Coronary Artery Calcification Is an Independent Stroke Predictor in the General Population , 2013, Stroke.
[7] I. Komuro,et al. Elevated serum heart-type fatty acid-binding protein in the convalescent stage predicts long-term outcome in patients surviving acute myocardial infarction. , 2013, Circulation journal : official journal of the Japanese Circulation Society.
[8] M. Volpe,et al. Circulating biomarkers with preventive, diagnostic and prognostic implications in cardiovascular diseases. , 2012, International journal of cardiology.
[9] C. Stephan,et al. Fatty acid binding proteins (FABPs) in prostate, bladder and kidney cancer cell lines and the use of IL-FABP as survival predictor in patients with renal cell carcinoma , 2011, BMC Cancer.
[10] C. Sudlow,et al. Association of Circulating Inflammatory Markers With Recurrent Vascular Events After Stroke: A Prospective Cohort Study , 2011, Stroke.
[11] V. Salomaa,et al. Contribution of 30 Biomarkers to 10-Year Cardiovascular Risk Estimation in 2 Population Cohorts: The MONICA, Risk, Genetics, Archiving, and Monograph (MORGAM) Biomarker Project , 2010, Circulation.
[12] J. Campisi,et al. Inflammatory networks during cellular senescence: causes and consequences. , 2010, Trends in molecular medicine.
[13] P. Whincup,et al. Circulating inflammatory and hemostatic biomarkers are associated with risk of myocardial infarction and coronary death, but not angina pectoris, in older men , 2009, Journal of thrombosis and haemostasis : JTH.
[14] R. Effros,et al. Immunosenescence: what does it mean to health outcomes in older adults? , 2009, Current opinion in immunology.
[15] P. Macfarlane,et al. Are Markers of Inflammation More Strongly Associated with Risk for Fatal Than for Nonfatal Vascular Events? , 2009, PLoS medicine.
[16] P. Gambert,et al. Prognostic value of N-terminal pro-brain natriuretic peptide in elderly people with acute myocardial infarction: prospective observational study , 2009, BMJ : British Medical Journal.
[17] F. Harrell,et al. Criteria for Evaluation of Novel Markers of Cardiovascular Risk: A Scientific Statement From the American Heart Association , 2009, Circulation.
[18] C. Choi,et al. Estimating the probability of stroke in Korean hypertensive patients visiting tertiary hospitals using a risk profile from the framingham study , 2009, BMC neurology.
[19] F. Taccone,et al. First-ever stroke as initial presentation of systemic cancer. , 2008, Journal of stroke and cerebrovascular diseases : the official journal of National Stroke Association.
[20] Anders Larsson,et al. Use of multiple biomarkers to improve the prediction of death from cardiovascular causes. , 2008, The New England journal of medicine.
[21] M. Pencina,et al. Evaluating the added predictive ability of a new marker: From area under the ROC curve to reclassification and beyond , 2008, Statistics in medicine.
[22] A. Maisel,et al. Natriuretic peptides. , 2007, Journal of the American College of Cardiology.
[23] A. Hall,et al. Heart-type fatty acid-binding protein predicts long-term mortality after acute coronary syndrome and identifies high-risk patients across the range of troponin values. , 2007, Journal of the American College of Cardiology.
[24] S. Gutnikov,et al. Effect of urgent treatment of transient ischaemic attack and minor stroke on early recurrent stroke (EXPRESS study): a prospective population-based sequential comparison , 2007, The Lancet.
[25] B. Yoon,et al. Stroke as the first manifestation of concealed cancer , 2007, Journal of the Neurological Sciences.
[26] M. Kivimäki,et al. Does personality predict mortality? Results from the GAZEL French prospective cohort study. , 2007, International journal of epidemiology.
[27] H J Rupprecht,et al. Haemostatic Factors and the Risk of Cardiovascular Death in Patients With Coronary Artery Disease: The AtheroGene Study , 2006, Arteriosclerosis, thrombosis, and vascular biology.
[28] R. Sacco,et al. High-sensitivity C-reactive protein, lipoprotein-associated phospholipase A2, and outcome after ischemic stroke. , 2006, Archives of internal medicine.
[29] Tatsuo Kanda,et al. Fatty Acid Binding Protein 6 Is Overexpressed in Colorectal Cancer , 2006, Clinical Cancer Research.
[30] G. Lowe,et al. Which Hemostatic Markers Add to the Predictive Value of Conventional Risk Factors for Coronary Heart Disease and Ischemic Stroke?: The Caerphilly Study , 2005, Circulation.
[31] A. Algra,et al. Long-term survival and vascular event risk after transient ischaemic attack or minor ischaemic stroke: a cohort study , 2005, The Lancet.
[32] W. Hermens,et al. Fatty acid-binding proteins as plasma markers of tissue injury. , 2005, Clinica chimica acta; international journal of clinical chemistry.
[33] P. Rothwell,et al. Direct Assessment of Completeness of Ascertainment in a Stroke Incidence Study , 2004, Stroke.
[34] T. Sugino,et al. Expression of Heart-Type Fatty Acid-Binding Protein in Human Gastric Carcinoma and Its Association with Tumor Aggressiveness, Metastasis and Poor Prognosis , 2004, Pathobiology.
[35] David B Matchar,et al. Charlson Index Comorbidity Adjustment for Ischemic Stroke Outcome Studies , 2004, Stroke.
[36] S. Gutnikov,et al. Change in stroke incidence, mortality, case-fatality, severity, and risk factors in Oxfordshire, UK from 1981 to 2004 (Oxford Vascular Study) , 2004, The Lancet.
[37] G. Baxter. The natriuretic peptides , 2004, Basic Research in Cardiology.
[38] T. G. Clark,et al. Long term risks of stroke, myocardial infarction, and vascular death in “low risk” patients with a non-recent transient ischaemic attack , 2003, Journal of neurology, neurosurgery, and psychiatry.
[39] J. Lodder,et al. Stroke subtype and mortality. a follow-up study in 998 patients with a first cerebral infarct. , 2003, Journal of clinical epidemiology.
[40] D. Levy,et al. Impact of age and sex on plasma natriuretic peptide levels in healthy adults. , 2002, The American journal of cardiology.
[41] Hugo A. Katus,et al. Myocardial infarction redefined--a consensus document of The Joint European Society of Cardiology/American College of Cardiology Committee for the redefinition of myocardial infarction. , 2000, European heart journal.
[42] H. Cohen,et al. Associations of elevated interleukin-6 and C-reactive protein levels with mortality in the elderly. , 1999, The American journal of medicine.
[43] F. Spener,et al. Chapter 10 - Fatty Acid Binding Proteins , 1994 .
[44] R B D'Agostino,et al. Probability of stroke: a risk profile from the Framingham Study. , 1991, Stroke.
[45] P. Sandercock,et al. Progress Review Blood Markers for the Prognosis of Ischemic Stroke A Systematic Review , 2009 .
[46] M. Bayes,et al. The Probability of , 2001 .
[47] S. Hatano,et al. Experience from a multicentre stroke register: a preliminary report. , 1976, Bulletin of the World Health Organization.